Health Catalyst Target Price

See Health Catalyst's analyst price targets ($2.2) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$1.7

Average Target Price

$2.18

28.4% upside

3 analysts in the last 4 months

High: $3 | Low: $1.75

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-20	Canaccord Genuity	$1.8	5.9% upside
2026-07-21	Canaccord Genuity	$3	76.5% upside
2026-06-26	Wells FargoStan Berenshteyn	$1.75	2.9% upside
2026-05-12	Stephens	$1.75	2.9% upside
2026-03-13	Raymond JamesSarah James	$3	76.5% upside
2026-03-13	Canaccord GenuityRichard Close	$2	17.6% upside
2025-10-08	Evercore ISI	$3	76.5% upside
2025-10-08	KeyBanc	$4	135.3% upside
2025-08-29	Canaccord GenuityRichard Close	$5	194.1% upside
2025-08-29	Summit Redstone Partners	$5	194.1% upside
2025-04-16	KeyBancScott Schoenhaus	$5	194.1% upside
2025-03-06	Stephens	$5	194.1% upside
2025-01-14	RBC CapitalSean Dodge	$7	311.8% upside
2024-09-03	Canaccord GenuityRichard Close	$11	547.1% upside
2024-08-26	Piper SandlerJessica Tassan	$11	547.1% upside
2024-08-08	StephensJeff Garro	$7	311.8% upside
2024-06-06	Piper SandlerJessica Tassan	$14	723.5% upside
2024-01-26	GuggenheimJack Wallace	$14	723.5% upside
2022-05-11	Piper SandlerJessica Tassan	$21	1135.3% upside
2022-03-02	RBC CapitalSean Dodge	$35	1958.8% upside
2022-03-02	Evercore ISIElizabeth Anderson CFA	$48	2723.5% upside
2022-02-11	Goldman SachsCindy Motz CFA	$48	2723.5% upside
2021-05-27	GuggenheimSandy Draper	$60	3429.4% upside
2021-05-07	Cantor FitzgeraldSteven Halper	$60	3429.4% upside

Health Catalyst (HCAT) FAQ

The latest target price for HCAT is $2.2. Investors often review this figure alongside Health Catalyst's historical trend and sector peers before judging valuation or financial health.

Health Catalyst trades near $1.7 while the consensus target sits at $2.2 (28.4% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting HCAT's target price ($2.2), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Health Catalyst's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.